Positive
Beyond's analysis on Positive
Recent news mentioning Positive
- — Boeing's Free Cash Flow Turned Positive. Here's What Has to Happen Next for the Turnaround to Stick.
- — Clover Announces Positive Phase 2 Clinical Data for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates in Older Adults
- — Argo Biopharma to Present Positive Phase II Updated Results of siRNA Therapeutic BW-20805 for HAE at Bradykinin Symposium 2026
- — C3.ai Bookings Jumped 73% and Free Cash Flow Turned Positive. Is the $7 Bear Case Breaking?
- — AbbVie Announces Positive Topline Results from the Phase 3 CERVINO Trial Showing Etentamig Significantly Improved Response Rate and Progression-Free Survival in Patients with Relapsed/Refractory Multiple Myeloma
- — Amber International Holding Limited Accelerates Specialized AI Agent Transformation as Q2 Revenue Grows 38.8% Quarter-over-Quarter and Profitability Turns Positive
- — Ivonescimab Meets Overall Survival Key Secondary Endpoint in Interim Analysis of Phase III HARMONi-2 Study, Demonstrating Statistically Significant and Clinically Meaningful Benefit Versus Pembrolizumab in First-Line PD-L1-Positive NSCLC
- — Raziel Therapeutics and Fosun Pharma Announce Positive Phase 3 Results for RZL-012 in Submental Fat Reduction, Clearing the Path to a China NDA Filing
- — Canada's Drug Agency issues final positive recommendation supporting public reimbursement of Leqembi®
- — Canada's Drug Agency issues final positive recommendation supporting public reimbursement of Leqembi®
- — After an 'extraordinary' earnings season, here's the next big positive for stocks
- — Urgent: maximise the positive uses of AI